Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
In 2017, China consumption volume reached 1907.5 K Units, due to the bigger demand of downstream applications and the larger population and policy support; while Europe consumed 725.4 K Units and Japan consumed 362.7 K Units.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion.

According to this study, over the next five years the Hemoperfusion production market will register a 13.4% CAGR in terms of revenue, the global market size will reach USD 690 million by 2024, from USD 320 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemoperfusion production business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion production market by product type, application, key manufacturers and key regions and countries.

This study considers the Hemoperfusion production value and volume generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Resin Adsorption
Activated Carbon Adsorption
Others
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Hemoperfusion production consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemoperfusion production market by identifying its various subsegments.
Focuses on the key global Hemoperfusion production manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemoperfusion production with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemoperfusion production submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.